Hercules Capital offers a forward P/E of 7.8x, a PEG of 0.70, and analysts implying roughly 25% upside — set against operating margins of 60% and a Rule of 40 score of 63 — but a confirmed technical downtrend with a declining 200-day moving average and negative volume accumulation argues for holding rather than adding until the technical picture improves.
Thesis pillars
- Attractive Valuation Analyst Upside→Stable
- Consistent Earnings Delivery↑Improving
- Confirmed Technical Downtrend Headwind↓Deteriorating
- +1 more pillar — see the Why tab for full reasoning
Hercules Capital, Inc. (HTGC) Stock Analysis
Financial Services · Asset Management
Hold if already holding. Not a fresh buy at $16.76, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5.
Hercules Capital is an internally managed BDC regulated under the Investment Company Act of 1940 that provides senior secured loans and Structured Debt to venture capital-backed and institutional-backed companies in technology and life sciences sectors. The company has... Read more
Hold if already holding. Not a fresh buy at $16.76, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.3/10, moderate confidence.
Passes 6/9 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 74d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
About Hercules Capital, Inc.
About Hercules Capital, Inc.
Hercules Capital has originated over $25.0 billion in commitments since inception through December 31, 2025, investing in venture capital-backed and institutional-backed technology and life sciences companies as a BDC regulated under the Investment Company Act of 1940. Portfolio fair value at year-end was approximately 87.1% concentrated in five industries, led by Application Software (24.3%) and Drug Discovery & Development (23.3%). The company held warrant and equity securities in 164 portfolio companies, with 97.9% of loans priced at floating rates of approximately 7% to 14%.
Hercules earns investment income primarily from interest and fees on Structured Debt—senior secured term loans with embedded warrants, equity options, or conversion rights—carrying maturities of 36 to 48 months. As an internally managed BDC, the company incurs operating costs directly rather than paying an external adviser, avoiding the management fee structure of externally managed peers. Income is supplemented by exit fees, balloon payment fees, commitment fees, and prepayment fees, while warrant and equity co-investments provide upside exposure at portfolio company liquidity events. The 1940 Act requires a minimum 150% asset-coverage ratio on borrowings, constraining available debt financing. An Adviser Subsidiary—separately registered as a registered investment adviser—manages third-party funds for external investors, generating supplemental advisory fee income. The company focuses on companies backed by established venture capital and private equity sponsors; as of December 31, 2025, debt investments targeted total annualized returns of 10% to 20%.
Show full overview
The 87.1% portfolio concentration across five technology and life sciences sectors creates correlated default risk the 10-K explicitly identifies: a downturn in any heavily concentrated sector could materially affect Hercules more than a diversified portfolio would. The Drug Discovery & Development sector at 23.3% of fair value is subject to binary FDA approval outcomes, patent expiration, and third-party payer reimbursement changes. The Application Software sector at 24.3% faces subscription renewal volatility and AI-driven competitive disruption the 10-K names specifically. Compounding this, Hercules is classified as non-diversified under the 1940 Act, meaning no regulatory minimum diversification requirement constrains single-issuer exposure beyond its RIC tax requirements.
See also: Financial Services · Asset Management
From Hercules Capital, Inc.'s most recent 10-K filing, extracted June 10, 2026.
Recent developments
updated 2026-08-16Recent Developments — Hercules Capital, Inc.
Latest news
- NEWS Hercules Capital Earnings: What To Look For From HTGC - StockStory — StockStory neutral
- NEWS Hercules Capital Earnings: What To Look For From HTGC - TradingView — TradingView neutral
- NEWS Hercules Capital Earnings: What To Look For From HTGC - tradingview.com — tradingview.com neutral
- NEWS HTGC Investor Alert: Hercules Capital Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action — PR Newswire negative
- NEWS Hercules Capital (HTGC) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance — Yahoo Finance negative
Generated 2026-08-16T12:27:03Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- LOWloan_portfolioApplication Software industry24%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio comprised investments in five industries: 24.3% comprised investments in the "Application Software" industry'
- LOWloan_portfolioDrug Discovery & Development industry23%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 23.3% comprised investments in the "Drug Discovery & Development" industry'
- LOWloan_portfolioHealthcare Services, Other industry19%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 18.8% comprised investments in the "Healthcare Services, Other" industry'
- LOWloan_portfolioSystem Software industry11%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 10.6% in the "System Software" industry'
- LOWloan_portfolioConsumer & Business Services industry10%10-K Item 1A: 'approximately 87.1% of the fair value of our portfolio ... 10.1% comprised investments in the "Consumer & Business Services" industry'
Material Events(8-K, last 90d)
- 2026-05-04Item 5.02MEDIUMCFO Seth H. Meyer (CFO since March 2019) transitions to President effective May 18, 2026, continuing to report to CEO Scott Bluestein. Andrew Olson, age 43, named to leadership team effective May 18, 2026 (successor CFO role implied; body truncated).SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
10 dimensions · all in-band
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $16.76, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $19.20 (+14.6%), stop $15.96 (−5.0%), A.R:R -0.0:1. Score 6.3/10, moderate confidence.
Take-profit target: $19.20 (-0.1% upside). Target $19.20 (+14.6%), stop $15.96 (−5.0%), A.R:R -0.0:1. Stop-loss: $15.96.
Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.0): -0.5.
Hercules Capital, Inc. trades at a P/E of 8.3 (forward 8.5). TrendMatrix value score: 7.5/10. Verdict: Hold.
15 analysts cover HTGC with a consensus score of 4.1/5. Average price target: $19.
What does Hercules Capital, Inc. do?Hercules Capital is an internally managed BDC regulated under the Investment Company Act of 1940 that provides senior...
Hercules Capital is an internally managed BDC regulated under the Investment Company Act of 1940 that provides senior secured loans and Structured Debt to venture capital-backed and institutional-backed companies in technology and life sciences sectors. The company has originated over $25.0 billion in commitments since inception through December 31, 2025, earning investment income from floating-rate loans (97.9% of portfolio) priced at approximately 7% to 14%.